Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
novumprs.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Novum Pharmaceutical Research Services

Novum Pharmaceutical Research is a full-service CRO that conducts studies across multiple therapeutic areas and has developed long-standing relationships with a range of global sponsors who rely on its early phase research and clinical trial management expertise.

Novum Pharmaceutical Research Services Headquarter Location

225 W. Station Square Drive Suite 200

Pittsburgh, Pennsylvania, 15219,

United States

412-362-3300

Latest Novum Pharmaceutical Research Services News

Novum Expands North American Services With Consolidation Of A Canadian Clinical Facility

Jul 21, 2020

Novum Expands North American Services With Consolidation Of A Canadian Clinical Facility PITTSBURGH, July 21, 2020 /PRNewswire/ -- Novum Pharmaceutical Research Services announced today an expansion of its services in North America. Author: Jul 21, 2020 10:14 AM EDT PITTSBURGH, July 21, 2020 /PRNewswire/ -- Novum Pharmaceutical Research Services announced today an expansion of its services in North America. Novum, one of the world's leading Contract Research Organizations (CRO) for almost fifty years, has consolidated Lambda Therapeutic Research's Toronto, Canada clinic and bioanalytical laboratory into Novum operations. This follows the 2019 acquisition of Novum by Lambda. The enhanced Novum organization will serve global clients throughout its operations in Pennsylvania, North Dakota, Nevada and Toronto, Canada. The Canadian site, which was founded in 2010, offers additional capacity to provide clinical services including Phase I (First-in-Human), Pharmacokinetics (PK), Pharmacodynamic (PD), Drug-Drug Interaction studies (DDI), Dose Escalation (SAD/MAD), Safety, Tolerability, Dose Ranging, and Patient PK studies. With state-of-the-art instrumentation, Novum Canada's bioanalytical lab has developed over 400 assays involving small and large molecules in its GLP compliant facility. Novum Canada's scientists routinely develop and validate methods and analyze over 15,000 samples a month, including proprietary methods for NCE and generic molecules with sub picogram detection, endogenous, chiral and hormonal assays. For additional information, prospective customers can visit www.novumprs.com , email Tausif Monif, President, Global Operations at tmonif@novumprs.com , or email Novum CEO Christopher H. Chamberlain at chchamberlain@novumprs.com . About Novum Pharmaceutical Research ServicesA leading Contract Research Organization (CRO) since 1972, Novum has been considered one of the world's leaders in the conduct of clinical trials, from First in Human studies to Late Phase Research requiring patient populations across multiple therapeutic areas. Novum provides bioanalytical services and full-service scientific support in medical writing and statistical analysis. The company is headquartered in Pittsburgh, Pennsylvania with operations in Toronto, North Dakota and Nevada. For more information, visit  www.novumprs.com . View original content: http://www.prnewswire.com/news-releases/novum-expands-north-american-services-with-consolidation-of-a-canadian-clinical-facility-301096344.html

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.